Arcturus Therapeutics Holdings Inc. Common Stock (NASDAQ: ARCT) last traded at $13.45, up 22.38% on the session. The quote above updates while this page is open; the figures below are drawn from Arcturus Therapeutics Holdings Inc. Common Stock’s own filings and are restated only when a new one is published.
Arcturus Therapeutics Holdings Inc. Common Stock trades on NASDAQ under the ticker ARCT. Its market capitalisation is $382.29 million.
Valuation measures for Arcturus Therapeutics Holdings Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $382.29M |
|---|---|
| Enterprise value | $243.31M |
| Price / sales | 13.02 |
| Price / book | 2.23 |
| Beta | 1.98 |
Trailing-twelve-month figures tagged in Arcturus Therapeutics Holdings Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $29.37M |
|---|---|
| Net income (TTM) | -$93.28M |
| EPS (TTM) | -$3.33 |
| Operating margin | -348.32% |
| Return on equity | -54.29% |
| Cash | $191.48M |
Range and volume for ARCT over the past 52 weeks.
| 52-week high | $24.17 |
|---|---|
| 52-week low | $5.50 |
| Volume | 2.85M |
| Average volume | 644.9K |
| Previous close | $10.99 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.